Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

32
Number of overlapping holdings
82.1%
% of IHE's 35 holdings also in XPH
86.5%
% of XPH's 40 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IHE |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 27.9% | 5.6% | 5.6% | |
ZOETIS INC | 4.7% | 4.8% | 4.7% | |
VIATRIS, INC. | 4.2% | 4.5% | 4.2% | |
MERCK & CO. INC. | 4.2% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 19.9% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
ELI LILLY & CO | 22.3% | |
JOHNSON & JOHNSON | 15.9% | |
AMICUS THERAPEUTICS INC | 1.2% | |
MADRIGAL PHARMACEUTICALS, INC. | 0.8% | |
CATALYST PHARMACEUTICAL PART | 0.4% | |
IRONWOOD PHARMACEUTICALS INC | 0.4% | |
VANDA PHARMACEUTICALS INC | 0.1% | |
PHIBRO ANIMAL HEALTH CORP-A | 0.1% | |
ATEA PHARMACEUTICALS, INC. | 0.1% | |
MERCK & CO. INC. | 0.0% |
IHE Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -6.1% | |
ELANCO ANIMAL HEALTH, INC. | -3.7% | |
AXSOME THERAPEUTICS, INC. | -3.4% | |
VENTYX BIOSCIENCES, INC. | -2.6% | |
CATALENT INC | -2.3% | |
CYMABAY THERAPEUTICS, INC. | -2.1% | |
PERRIGO CO | -2.1% | |
ORGANON & CO. | -2.1% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.9% | |
INTRA-CELLULAR THERAPIES INC | -1.8% |